cold chain management SOP – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Sat, 04 Oct 2025 13:14:00 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Vaccine Trial Cold-Chain Management (Mass Trials) https://www.clinicalstudies.in/sop-for-vaccine-trial-cold-chain-management-mass-trials/ Sat, 04 Oct 2025 13:14:00 +0000 ]]> https://www.clinicalstudies.in/?p=7055 Read More “SOP for Vaccine Trial Cold-Chain Management (Mass Trials)” »

]]>
SOP for Vaccine Trial Cold-Chain Management (Mass Trials)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-vaccine-trial-cold-chain-management-mass-trials”
},
“headline”: “SOP for Vaccine Trial Cold-Chain Management (Mass Trials)”,
“description”: “This SOP defines standardized procedures for cold-chain management in vaccine clinical trials, particularly mass vaccination trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements, covering receipt, storage, transport, monitoring, accountability, and deviation handling of vaccines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Vaccine Trial Cold-Chain Management (Mass Trials)

SOP No. CR/OPS/115/2025
Supersedes NA
Page No. 1 of 62
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to establish standardized procedures for cold-chain management of vaccines in clinical trials, with a focus on large-scale and mass vaccination trials. Proper cold-chain practices ensure product stability, subject safety, and compliance with international regulatory requirements.

Scope

This SOP applies to sponsors, CROs, investigators, site pharmacists, couriers, and laboratory staff involved in the receipt, storage, transport, and distribution of vaccines used in clinical trials. It covers cold-chain monitoring, accountability, excursion management, multi-site logistics, and regulatory compliance.

Responsibilities

  • Sponsor: Ensures validated cold-chain systems are in place and audits compliance.
  • Investigator: Oversees vaccine receipt, storage, and distribution at site level.
  • Pharmacist/Site Staff: Responsible for storage, monitoring, accountability, and reporting deviations.
  • CRO: Monitors adherence to cold-chain requirements across sites.
  • Courier: Maintains validated shipping conditions during transport.
  • QA: Audits cold-chain management and reviews deviation reports.

Accountability

The Sponsor’s Vaccine Supply Chain Lead is accountable for cold-chain compliance. The Investigator is accountable for site-level cold-chain management.

Procedure

1. Vaccine Receipt
1.1 Verify shipment condition, temperature monitors, and integrity upon arrival.
1.2 Document details in Vaccine Receipt Log (Annexure-1).
1.3 Report discrepancies immediately to sponsor and QA.

2. Storage
2.1 Store vaccines in validated refrigerators/freezers with continuous monitoring.
2.2 Maintain temperature ranges (e.g., +2°C to +8°C or per product label).
2.3 Document in Vaccine Storage Log (Annexure-2).

3. Distribution and Transport
3.1 Use validated shippers and cold-chain packaging.
3.2 Document distribution in Vaccine Distribution Log (Annexure-3).

4. Temperature Monitoring
4.1 Use calibrated data loggers with alarms.
4.2 Review temperature records daily.
4.3 Record in Temperature Monitoring Log (Annexure-4).

5. Excursion Management
5.1 Document all excursions in Excursion Log (Annexure-5).
5.2 Notify sponsor QA and regulatory authorities if excursions exceed thresholds.

6. Accountability
6.1 Reconcile doses received, used, destroyed, or returned.
6.2 Record in Vaccine Accountability Log (Annexure-6).

7. Multi-Site Logistics
7.1 Coordinate shipments across sites with validated logistics partners.
7.2 Document in Multi-Site Logistics Log (Annexure-7).

8. Archiving
8.1 Archive all cold-chain records in TMF and ISF.
8.2 Retain records per regulatory requirements.

Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • TMF: Trial Master File
  • ISF: Investigator Site File
  • GCP: Good Clinical Practice
  • FDA: Food and Drug Administration
  • EMA: European Medicines Agency
  • CDSCO: Central Drugs Standard Control Organization
  • WHO: World Health Organization

Documents

  1. Vaccine Receipt Log (Annexure-1)
  2. Vaccine Storage Log (Annexure-2)
  3. Vaccine Distribution Log (Annexure-3)
  4. Temperature Monitoring Log (Annexure-4)
  5. Excursion Log (Annexure-5)
  6. Vaccine Accountability Log (Annexure-6)
  7. Multi-Site Logistics Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Vaccine Logistics Officer
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Vaccine Receipt Log

Date Shipment ID Vaccine Received By Condition
01/09/2025 SHIP-101 COVID-19 Vaccine Pharmacist Acceptable

Annexure-2: Vaccine Storage Log

Date Vaccine ID Storage Temp Checked By Status
02/09/2025 VAC-101 +4°C Site Technician Stable

Annexure-3: Vaccine Distribution Log

Date Shipment ID Destination Transporter Status
03/09/2025 SHIP-101 Site-2 Courier Delivered

Annexure-4: Temperature Monitoring Log

Date Equipment ID Min Temp Max Temp Reviewed By
04/09/2025 FRZ-01 +2°C +7°C QA Officer

Annexure-5: Excursion Log

Date Vaccine ID Excursion Impact Corrective Action
05/09/2025 VAC-101 +12°C for 4 hrs Moderate Investigated – Product Approved for Use

Annexure-6: Vaccine Accountability Log

Date Vaccine ID Doses Received Doses Used Doses Remaining
06/09/2025 VAC-101 1000 600 400

Annexure-7: Multi-Site Logistics Log

Date Shipment ID Sites Covered Coordinator Status
07/09/2025 SHIP-102 Site-1, Site-2, Site-3 Logistics Manager Completed

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Operations

For more SOPs visit: Pharma SOP

]]>
SOP for Cold Chain Management for Samples and IP https://www.clinicalstudies.in/sop-for-cold-chain-management-for-samples-and-ip/ Thu, 18 Sep 2025 22:37:14 +0000 ]]> https://www.clinicalstudies.in/?p=7026 Read More “SOP for Cold Chain Management for Samples and IP” »

]]>
SOP for Cold Chain Management for Samples and IP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-cold-chain-management-for-samples-and-ip”
},
“headline”: “SOP for Cold Chain Management for Samples and IP”,
“description”: “This SOP defines standardized procedures for managing cold chain storage and transport of biological samples and investigational products (IP) in clinical trials. It covers storage conditions, temperature monitoring, excursion handling, courier qualification, and regulatory compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Cold Chain Management for Samples and Investigational Products

SOP No. CR/OPS/085/2025
Supersedes NA
Page No. 1 of 42
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to establish standardized, regulatory-compliant procedures for cold chain management of biological samples and investigational products (IP) during clinical trials. This ensures product stability, subject safety, and data integrity by maintaining required storage and transport temperatures.

Scope

This SOP applies to sponsors, investigators, CROs, site staff, laboratories, and vendors involved in the storage, handling, shipment, and monitoring of temperature-sensitive samples and investigational products. It covers refrigerated (2–8°C), frozen (−20°C, −80°C), and cryogenic storage (liquid nitrogen).

Responsibilities

  • Sponsor: Provides requirements for cold chain management, qualifies vendors, and ensures compliance.
  • Investigator: Ensures site-level cold chain compliance and documentation.
  • Clinical Staff: Monitors, documents, and reports excursions.
  • Laboratory Staff: Ensures proper storage and timely processing of samples.
  • Courier: Maintains validated cold chain transport and documents chain of custody.
  • QA: Audits cold chain documentation and verifies compliance.

Accountability

The Sponsor is accountable for global compliance with cold chain requirements. Investigators are accountable for maintaining cold chain integrity at site. QA ensures oversight, auditing, and inspection readiness.

Procedure

1. Storage Conditions
1.1 Store samples and IPs at specified conditions per protocol.
1.2 Use validated refrigerators, freezers, and cryogenic storage units.
1.3 Maintain temperature mapping and calibration certificates.

2. Temperature Monitoring
2.1 Equip all cold chain units with calibrated temperature probes.
2.2 Implement continuous monitoring with alarms for out-of-range conditions.
2.3 Record temperatures twice daily in Cold Chain Temperature Log (Annexure-1).

3. Excursion Management
3.1 Document excursions in Temperature Excursion Log (Annexure-2).
3.2 Immediately notify Sponsor and QA for assessment.
3.3 Quarantine affected samples/IP until disposition is determined.

4. Shipment
4.1 Use validated thermal shippers with dry ice or gel packs.
4.2 Include temperature monitoring devices in shipments.
4.3 Maintain Chain of Custody Log (Annexure-3).

5. Equipment Qualification
5.1 Perform installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) of cold chain equipment.
5.2 Retain qualification records in Equipment Qualification Log (Annexure-4).

6. Courier/Vendor Oversight
6.1 Only qualified vendors with documented validation may transport samples/IP.
6.2 QA to review courier temperature logs and deviation reports.

7. Documentation
7.1 Maintain Cold Chain File with all logs, deviations, and corrective actions.
7.2 Ensure records are inspection-ready at all times.

Abbreviations

  • SOP: Standard Operating Procedure
  • IP: Investigational Product
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • IQ/OQ/PQ: Installation/Operational/Performance Qualification
  • CAPA: Corrective and Preventive Action

Documents

  1. Cold Chain Temperature Log (Annexure-1)
  2. Temperature Excursion Log (Annexure-2)
  3. Chain of Custody Log (Annexure-3)
  4. Equipment Qualification Log (Annexure-4)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Clinical Coordinator
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Principal Investigator

Annexures

Annexure-1: Cold Chain Temperature Log

Date Time Equipment Temperature Recorded By
15/09/2025 09:00 Refrigerator-01 4°C Meena Sharma

Annexure-2: Temperature Excursion Log

Date Equipment Excursion Details Action Taken Disposition
16/09/2025 Freezer-02 −18°C for 3 hrs QA notified, samples quarantined Pending Sponsor decision

Annexure-3: Chain of Custody Log

Date Sample/IP ID From To Condition Signature
18/09/2025 IP-B001 Site-01 Central Lab 2–8°C maintained Signed

Annexure-4: Equipment Qualification Log

Date Equipment Qualification Performed By Verified By
01/09/2025 Freezer-02 PQ Completed Engineer QA Officer

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Quality

For more SOPs visit: Pharma SOP

]]>